Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats

Brain Research

Volumn 872, Issue 1-2, 2000, Pages 44-53

  Berman, Robert F ^a   Fredholm, Bertil B ^b   Aden, Ulrika ^b   O'Connor, William T ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Adenosine; Adenosine deaminase; Bicuculline; Epilepsy; Hippocampus; Hypoxanthine; Inosine; Ka inate; Microdialysis; Pentylenetetrazol; Xanthine

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; BICUCULLINE; HYPOXANTHINE; INOSINE; KAINIC ACID; PENTETRAZOLE; XANTHINE;

ADOLESCENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0034725830     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02441-0     Document Type: Article

References (49)

1. P.W. Achterberg J.W. de Jong Adenosine deaminase inhibition and myocardial adenosine metabolism during ischemia Adv. Myocardiol. 6 1985 465 472
2. R.A. Barraco T.H. Swanson J.W. Phillis R.F. Berman Anticonvulsant effects of adenosine analogues on amygdaloid-kindled seizures in rats Neurosci. Lett. 46 1984 317 322
3. M. Ballarin B.B. Fredholm S. Ambrosio N. Mahy Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism Acta Physiol. Scand. 142 1991 97 103
4. R.F. Berman M.F. Jarvis C.R. Lupica Adenosine involvement in kindled seizures J.A. Wada Kindling, 4 1990 Plenum Press New York 423 435
5. J.M. Brundege L. Diao W.R. Proctor T.V. Dunwiddie The role of cyclic AMP as a precursor of extracellular adeosine in the rat hippocampus Neuropharmacy 36 1997 1201 1210
6. J.M. Brundege T.V. Dunwiddie Role of adenosine as a modulator of synaptic activity in the central nervous system Adv. Pharmacol. 39 1997 353 391
7. H.V. Carswell D.I. Graham T.W. Stone Kainate-evoked release of adenosine from the hippocampus of the anesthetized rat: Possible involvement of free radicals J. Neurochem. 68 1997 240 247
8. J.J. Centelles R. Franco J. Bozal Purification and partial characterization of brain adenosine deaminase: inhibition by purine compounds and by drugs J. Neurosci. Res. 19 1988 258 267
9. W. Chen M. Gueron AMP degradation in the perfused rat heart during 2-deoxy- d -glucose perfusion and anoxia. Part II: The determination of the degradation pathways using an adenosine deaminase inhibitor J. Mol. Cell Cardiol. 28 1996 2175 2182
10. A.J.R. Chesi T.W. Stone Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro Exp. Brain Res. 113 1997 303 310
11. F. Ciruela C. Saura E.I. Canela J. Mallol C. Lluis R. Franco Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors FEBS Lett. 380 1996 219 223
12. D. Dobolyi A. Reichart T. Szikra N. Szilagyi A.K. Kekesi T. Karancsi P. Slegel M. Palkovits G. Juhasz Analysis of purine and pyrimidine bases, nucleosides and deoxynucleosides in brain microsamples (microdialysates and micropunches) and cerebrospinal fluid Neurochem. Int. 32 1998 247 256
13. M. Dragunow G.V. Goddard R. Laverty Is adenosine an endogenous anticonvulsant? Epilepsia 26 1985 480 487
14. T.V. Dunwiddie B.B. Fredholm Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize neurons in rat hippocampus J. Pharmacol. Exp. Ther. 249 1989 31 37
15. T.V. Dunwiddie T. Worth Anticonvulsant effects of adenosine analogs in mouse and rat J. Pharmacol. Exp. Ther. 220 1982 70 76
16. T.V. Dunwiddie L. Diao W.R. Proctor Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus J. Neurosci. 17 1997 7673 7682
17. M.J. During D.D. Spencer Adenosine: a potential mediator of seizure arrest and postictal refractoriness Ann. Neurol. 32 1992 618 624
18. 1-receptors and 5′-nucleotidase in the brain of some commonly used experimental animals Neuroscience 22 1987 813 826
19. W.N. Fishbein J.I. Davis J.W. Winkert D.M. Strong Levels of adenosine deaminase, AMP deaminase, and adenylate kinase in cultured human lymphoblast lines: exquisite sensitivity of AMP deaminase to adenosine deaminase inhibitors Biochem. Med. 26 1981 377 386
20. P.H. Franklin G. Zhang C.D. Tripp T.F. Murray Adenosine A1 receptor activation mediates suppression of (1)-bicuculline methiodide-induced seizures in rat prepiriform cortex J. Pharmacol. Exp. Ther. 251 1989 1229 1236
21. B.B. Fredholm M.P. Abbracchio G. Burnstock J.W. Daly T.K. Harden K.A. Jacobson P. Leff M. Williams VI Nomenclature and classification of purinoceptors Pharmacol. Rev. 46 1994 143 156
22. J.D. Geiger F.E. Parkinson D.A. Kowaluk Regulators of endogenous adenosine levels as therapeutic agents K.A. Jacobson M.F. Jarvis Purinergic Approaches in Experimental Therapeutics 1997 Wiley-Liss New York 59 81
23. 1 receptor number Brain Res. 612 1993 271 277
24. J.K. Hsiao B.A. Ball P.F. Morrison I.N. Mefford P.M. Bungay Effects of different semipermeable membranes on in vitro and in vivo performance of microdialysis probes J. Neurochem. 54 1990 1449 1452
25. C.A. Janusz R.F. Berman Adenosine analogs modulate EEG and locomotor effects of the A2 agonist, CGS21680 Pharm. Biochem. Behav. 45 1993 913 919
26. B. Johansson V. Georgiev T. Kuosmanen B.B. Fredholm Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c -fos expression and receptor binding Eur. J. Neurosci. 8 1996 2447 2458
27. D.A. Kowaluk S.S. Ghagwat M.F. Jarvis Adenosine kinase inhibitors Curr. Pharm. Design 4 1998 403 416
28. H.G.E. Lloyd B.B. Fredholm Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices Neurochem. Int. 26 1995 387 395
29. C.R. Lupica R.F. Berman M.F. Jarvis Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: an autoradiographic study Synapse 9 1991 95 102
30. M. Madeja U. Musshoff C. Lorra O. Pongs E.J. Speckmann Mechanism of action of the epileptogenic drug pentylenetetrazol on a cloned neuronal potassium channel Brain Res. 722 1996 59 70
31. P. Meghji A. Newby Sites of adenosine formation, action and inactivation in the brain Neurochem. Int. 16 1990 227 232
32. B.S. Meldrum Epilepsy and gamma-aminobutyric acid-mediated inhibition Int. Rev. Neurobiol. 17 1975 1 36
33. A.M. Michie M. Lobban T. Muller M.M. Harnett M.D. Houslay Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram Cell Signal 8 1996 97 110
34. M. Moraidis D. Bingmann Epileptogenic actions of xanthines in relation to their affinities for adenosine A1 receptors in CA3 neurons of hippocampal slices (guinea pig) Brain Res. 640 1994 140 145
35. 2A receptors Trends Pharmacol. Sci. 17 1996 364 372
36. R.W. Olson The GABA postsynaptic membrane receptor–ionophore complex. Site of action of convulsant and anticonvulsant drugs Mol. Cell. Biochem. 39 1981 261 279
37. T.S. Park D.G.L. Van Wylen R. Rubio R.M. Berne Interstitial fluid adenosine and saggital sinus blood flow during bicuculline-seizures in newborn piglets J. Cereb. Blood Flow Metab. 7 1987 633 639
38. J.B. Rosen R.F. Berman Differential effects of adenosine analogs on amygdala, hippocampus and caudate nucleus kindled seizures Epilepsia 28 1987 658 666
39. R. Rubio R.M. Berne E.L. Bockman R.R. Curnish Relationship between adenosine concentration and oxygen supply in rat brain Am. J. Physiol. 228 1975 1896 1902
40. H.J. Schaeffer C.F. Schwender Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines J. Med. Chem. 17 2-hydroxy-3-alkyl 1974 6 8
41. V. Schultz J.M. Lowenstein The purine nucleotide cycle. Studies of ammonia production and interconversions of adenine and hypoxanthine nucleotides and nucleosides by rat brain in situ J. Biol. Chem. 253 1978 1938 1943
42. J.L. Stringer K.L. Sowell Kainic acid, bicuculline, pentylenetetrazole and pilocarpine elicit maximal dentate activation in the anesthetized rat Epilepsy Res. 19 1994 11 21
43. D.K.J.E. Von Lubitz M.R. Carter S.I. Deutsch R.C. Lin C.S. Rick J. Mastropaolo Y. Meshulam K.A. Jacobson The effects of adenosine A3 receptor stimulation on seizures in mice Eur. J. Pharmacol. 275 1995 23 29
44. K. Whitcomb C.R. Lupica J.B. Rosen R.F. Berman Adenosine involvement in postictal events in amygdala-kindled rats Epilepsy Res. 6 1990 171 179
45. H.R. Winn J.E. Welsh C. Bryner R. Rubio R.M. Berne Brain adenosine production during the initial 60 seconds of bicuculline seizures in rats Acta Neurol. Scand. 72 1979 536 537
46. H.R. Winn J.E. Welsh R. Butio R.R.M. Berne Changes in brain adenosine during bicuculline-induced seizures in rats: Effects of hypoxia and altered systemic blood pressure Circ. Res. 47 1980 868 877
47. Y. Yamazaki A.R. Collinson V.L. Truong J.M. Lowenstein Regulation of soluble 5′-nucleotidase I from rabbit heart Adv. Exp. Med. Biol. 253B 1989 107 111
48. T. Zetterstrom L. Vernet U. Ungerstedt U. Rossman B. Jonzon B.B. Fredholm Purine levels in the intact brain Neurosci. Lett. 29 1982 111 115
49. G. Zhang P.H. Franklin T.F. Murray Activation of adenosine A1 receptors underlies anticonvulant effect of CGS21680 Eur. J. Pharmacol. 255 1994 239 243